Family · Pharmaceutical analytical standards
Celiprolol
A beta-blocker selective for beta-1 receptors, with partial stimulating action on beta-2 receptors, approved in 1982; it is used for hypertension and angina pectoris. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It has been studied in vascular Ehlers-Danlos syndrome, a rare collagen disorder: the BBEST trial, published in 2010, was stopped early because of the benefit seen.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
